Role of matrix metalloproteinase-9 in angiogenesis caused by ocular infection with herpes simplex virus

J Clin Invest. 2002 Oct;110(8):1105-11. doi: 10.1172/JCI15755.

Abstract

In this report, we demonstrate that herpes simplex virus (HSV) infection of the cornea results in the upregulation of the matrix-degrading metalloproteinase enzyme MMP-9. This enzyme was shown to contribute to the neovascularization process that occurs in the corneal stroma in response to HSV infection. The likely source of MMP-9, at least initially after infection, was neutrophils that were signaled to invade the cornea soon after infection. Corneal infiltrating neutrophils were shown to express MMP-9, and preventing the neutrophil response with specific mAb diminished MMP-9 expression as well as the extent of angiogenesis. Further supporting a role for MMP-9 in HSV-induced corneal angiogenesis was the observation that inhibition of MMP-9 with the specific inhibitor TIMP-1 resulted in reduced angiogenesis. In addition, angiogenesis was diminished in ocularly infected MMP-9 knockout mice. Our results demonstrate that MMP-9 is involved in angiogenesis caused by HSV. Since angiogenesis appears to represent a vital step in the pathogenesis of herpetic stromal keratitis, these results indicate that targeting MMP-9 for inhibition should prove useful for the therapy of herpetic stromal keratitis.

Publication types

  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Animals
  • DNA / drug effects
  • DNA / genetics
  • Endothelial Growth Factors / pharmacology
  • Female
  • Intercellular Signaling Peptides and Proteins / pharmacology
  • Keratitis, Herpetic / enzymology*
  • Keratitis, Herpetic / genetics
  • Keratitis, Herpetic / pathology*
  • Keratitis, Herpetic / physiopathology
  • Lymphocyte Depletion
  • Lymphokines / pharmacology
  • Matrix Metalloproteinase 9 / deficiency
  • Matrix Metalloproteinase 9 / genetics
  • Matrix Metalloproteinase 9 / physiology*
  • Matrix Metalloproteinase Inhibitors
  • Mice
  • Mice, Inbred BALB C
  • Mice, Knockout
  • Neovascularization, Pathologic / enzymology*
  • Neovascularization, Pathologic / etiology
  • Neovascularization, Pathologic / prevention & control
  • Neutrophils / physiology
  • Protease Inhibitors / pharmacology
  • Tissue Inhibitor of Metalloproteinase-1 / genetics
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors

Substances

  • Endothelial Growth Factors
  • Intercellular Signaling Peptides and Proteins
  • Lymphokines
  • Matrix Metalloproteinase Inhibitors
  • Protease Inhibitors
  • Tissue Inhibitor of Metalloproteinase-1
  • Vascular Endothelial Growth Factor A
  • Vascular Endothelial Growth Factors
  • DNA
  • Matrix Metalloproteinase 9